~~<i id='937E4E9369'><strike id='937E4E9369'><tt id='937E4E9369'><pre id='937E4E9369'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

author：leisure time 2025-09-29 09:30:01 - browse：36273

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Chan Zuckerberg Biohub Chicago to focus on inflammation

explore

entertainment

Wikipedia

focus

MollyFergusonforSTATSTATnowpublishesselectedLetterstotheEditorreceivedinresponsetoFirstOpinionessays

WSS

What STAT readers think about the FDA and patient advocacy

Readout Newsletter: The latest on Moderna, Apellis, and Merck

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Senate panel eyes new effort on drug shortages

The future of health care in the House

Violet CEO on training clinicians to promote more inclusive care

Wikipedia

Wikipedia

explore

New air purifier tech could be key to improving indoor air quality

CRISPR gene editing developments we’re watching in 2024

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Prime Medicine, Myeloid Therapeutics clash over genome

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Why Charlie Gard's case is so disturbing to Americans

DIEP, the 'gold standard' of breast reconstruction, is under threat

Why age limits for politicians are a terrible idea

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Colorectal cancer study finds potential in overlooked immune cell

explore

FDA authorizes Novavax’s updated Covid

SEC charges former device maker CEO with $41 million fraud

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Was Amgen transparent enough on FDA's concern on cancer drug?

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

Chemotherapy drug shortage eases slightly but still widespread

entertainment

Wikipedia

focus

focus